Radiopharm Theranostics Limited Sponsored ADR Financial Overview
Radiopharm Theranostics Limited Sponsored ADR's market cap is currently $64.28M. The company's EPS TTM is $-1.952; its P/E ratio is -1.59; Radiopharm Theranostics Limited Sponsored ADR is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is $-2.00. See an overview of income statement, balance sheet, and cash flow financials.
